Pharmaceutical Product Portfolio & Launch Governance
Coordinate product portfolio and launch activity across commercial, R&D, market access, regulatory and finance teams.
Para implemented a pharmaceutical product-portfolio and launch-governance platform coordinating sales and marketing, R&D, market access, regulatory affairs and finance across the product lifecycle with governed data, milestones, approvals, notifications, escalation and analytics.
Business challenge
- Product planning involved multiple central and local functions with different responsibilities.
- Milestones, approvals, notifications and escalation needed one governed lifecycle.
- Product information required fine-grained access and a clear local-versus-central governance model.
Para approach
- Define the pharmaceutical product and lifecycle information model.
- Map central and local roles across commercial, R&D, market access, regulatory and finance.
- Implement governed milestones and approval stages.
- Configure notifications, escalation and role-specific information access.
- Provide analytics over product and launch performance.
How it works
Validated product-portfolio and launch-governance implementation. Evidence: SRS, five-year business plan, technical and deployment documents, role-specific UAT and user and admin manuals.
Product / Market Inputs
Governed Product Model
Cross-functional Workflow
Milestones / Approvals
Notifications / Escalation
Portfolio Analytics
Delivered capability
Product portfolio model
Structured product and lifecycle information.
Cross-functional workflow
Commercial, R&D, market access, regulatory and finance coordination.
Milestones & approvals
Governed lifecycle checkpoints and decisions.
Notifications & escalation
Role-based reminders and escalation.
Fine-grained data governance
Controlled column and view permissions and stewardship.
Performance analytics
Reporting and analytics over portfolio and launch activity.
Evidence-supported outcomes
Cross-functional coordination
Different functions work against a common governed product lifecycle.
Governed product data
Product information is structured with defined stewardship and permissions.
Lifecycle visibility
Milestones, approvals and escalation provide clearer status across the portfolio.
Reusable pharma governance pattern
Provides a reusable model for product-centric regulated enterprise processes.
Technology & delivery context
Historical SharePoint-based solution with governed product information, workflow, notifications and escalation, role-specific permissions and analytics. The legacy implementation is delivery evidence, not a current product.
Have a similar enterprise challenge?
Para can assess the current state, define the business and information model, shape the architecture and delivery approach, and move from business need into implementation and ongoing operations.